Sophie Viaud
About Sophie Viaud
Sophie Viaud serves as the Associate Director and In Vivo Pharmacology Lead at Kite Pharma, where she has worked since 2021. With a strong background in immunology and extensive research experience, she has contributed significantly to the field, including publishing a notable article in Science on gut microbiota and chemotherapy efficiency.
Work at Kite Pharma
Sophie Viaud currently serves as the Associate Director and In Vivo Pharmacology Lead at Kite Pharma, a position she has held since 2021. In this role, she has led the in vivo development of multiple cell therapy programs, contributing to the advancement of the company's cell therapy pipeline. Prior to her current position, she worked as a Senior Research Scientist at Kite Pharma from 2020 to 2021. Her work focuses on designing and conducting in vivo studies, which are essential for the development of new immunotherapies.
Education and Expertise
Sophie Viaud holds a Doctor of Philosophy (Ph.D.) in Immunology from Université Paris Sud (Paris XI) - Ecole Doctorale de Cancérologie, where she studied from 2009 to 2013. She also earned a Bachelor's Degree in Génie biologique et informatique from Université d'Evry-Val d'Essonne from 1998 to 2001. Additionally, she obtained a Master's Degree in Modèles cellulaires in vitro from Université Paris XII Val de Marne in 2002. Her educational background provides a strong foundation for her expertise in immunology and pharmacology.
Background
Sophie Viaud has a diverse professional background in the field of immuno-oncology and pharmacology. She began her career with internships at GSK and CEA - Commissariat à l'énergie atomique et aux énergies alternatives in 2001 and 2002, respectively. She later worked as a Research Scientist at Hôpital Européen Georges Pompidou in 2004 and as a Postdoctoral Research Fellow at the California Institute for Biomedical Research (Calibr) from 2015 to 2018. Prior to joining Kite Pharma, she worked at Tocagen Inc. as a Research Scientist II in Translational Research from 2018 to 2019.
Achievements
Sophie Viaud has made significant contributions to the field of immunology and immuno-oncology, authoring 14 peer-reviewed articles in leading scientific publications. Notably, she published a leading article in Science that established a novel link between gut microbiota and chemotherapy efficiency. This research highlights her role in advancing scientific knowledge and her commitment to groundbreaking studies in her field.